Igor Roninson

13PUBLICATIONS
22CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 15, 2025
CDK8/19 inhibition attenuates G1 arrest induced by BCR-ABL antagonists and accelerates death of chronic myelogenous leukemia cells.

Alvina I Khamidullina, Margarita A Yastrebova, Alexandra V Bruter

|Nov 14, 2024
Mediator kinase inhibitors suppress triple-negative breast cancer growth and extend tumor suppression by mTOR and AKT inhibitors.

Xiaokai Ding, Jiaxin Liang, Amanda C Sharko

|Jun 28, 2023
Inhibition of Cyclin-Dependent Kinases 8/19 Restricts Bacterial and Virus-Induced Inflammatory Responses in Monocytes.

Elena K Kokinos, Sergey A Tsymbal, Anastasia V Galochkina

|Aug 01, 2022
Inhibition of CDK8/19 Mediator kinase potentiates HER2-targeting drugs and bypasses resistance to these agents in vitro and in vivo.

Xiaokai Ding, Amanda C Sharko, Martina S J McDermott

Pageof 3